Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)

NCT02866227 is registered in ClinicalTrials.gov with Toltec Pharmaceuticals, LLC as lead sponsor.

NCT NCT02866227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02866227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)
Lead sponsor
Toltec Pharmaceuticals, LLC
Phase
Phase 2
Overall status
Completed
Start date
July 15, 2016
Completion date
June 10, 2017
Enrollment
106 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bacterial vaginosis, vulvovaginal candidiasis